Anticancer agent 135

• Target :

  Androgen Receptor

• Related Pathways :

  Endocrinology/Hormones

• Bioactivity :

  Anticancer agent 135 (compound 26h) is a potent androgen receptor (AR) antagonist that blocks AR nuclear translocation and inhibits AR/AR-V7 heterodimerization to suppress downstream gene transcription, demonstrating strong efficacy in prostate cancer xenograft models [1].

• Molecular Formula :

  C23H21F3N4OS

• Molecular Weight :

  458.5

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C